+1
The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself
Stocks in this Quantisnow insightHealth Care · Technology
Historical context for AXGN
Across the 14 sessions after earlier AXGN headlines, the stock closed higher 9 times and lower 5 times, with a median move of 3.8% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | AXGN | SPY |
|---|---|---|---|
| Apr 30, 2026 | Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference | +3.4% | +1.0% |
| Apr 28, 2026 | Axogen, Inc. Reports First Quarter 2026 Financial Results | +6.6% | -0.5% |
| Apr 14, 2026 | Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026 | +3.0% | +1.2% |
| Feb 24, 2026 | Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results | -8.1% | +0.7% |
| Feb 19, 2026 | Wells Fargo initiated coverage on AxoGen with a new price target | -0.7% | -0.3% |
| Feb 17, 2026 | Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences | +4.2% | +0.2% |
Quantisnow market dataNASDAQ
AXGN
Axogen Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Electromedical & Electrotherapeutic Apparatus
Get push alerts for AXGN
Full AXGN profile on Quantisnow Follow AXGN and get a push notification the moment its next story breaks.